Igor Y. Khandros - May 14, 2021 Form 4 Insider Report for Berkeley Lights, Inc. (CELL)

Role
Director, 10%+ Owner
Signature
/s/ Stuart L. Merkadeau, Attorney-in-fact for Igor Khandros
Stock symbol
CELL
Transactions as of
May 14, 2021
Transactions value $
$0
Form type
4
Date filed
5/18/2021, 09:43 PM
Next filing
Aug 17, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CELL Common Stock Award $0 +1.4K +0.01% $0.00 9.71M May 14, 2021 See footnote F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CELL Stock Option (Right to Buy) Award $0 +4.9K $0.00 4.9K May 14, 2021 Common Stock 4.9K $37.13 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest on May 14, 2022 and have no expiration date.
F2 Consists of (i) 9,338,910 shares held by the Khandros-Bloch Revocable Trust U/A/D 1/24/1997 ("Revocable Trust"), (ii) 1,400 restricted stock units held by the Revocable Trust, (iii) 100,757 shares held by the Khandros 2018 3-Year GRAT (the "Khandros GRAT"), (iv) 100,757 shares held by the Bloch 2018 3-Year GRAT (the "Bloch GRAT"), (v) 85,602 shares held by the Khandros 2018 2-Year GRAT (the "Khandros 2-Year GRAT"), and (vi) 85,602 shares held by the Bloch 2018 2-Year GRAT (the "Bloch 2-Year GRAT", and together with the Khandros GRAT, Bloch GRAT, and Khandros 2-Year GRAT, the "GRATs"). As co-trustee of the Revocable Trust and the GRATs, Dr. Khandros may be deemed to beneficially own the shares held by the Revocable Trust and the GRATs. Dr. Khandros disclaims beneficial ownership of the shares held by the Revocable Trust and the GRATs except to the extent of his pecuniary interest therein.
F3 The stock option will fully vest on May 14, 2022.